Exascale Labs SPAC Merger Vote Set for July 29, 2026
Exascale Labs and D. Boral ARC Acquisition I Corp. have scheduled a shareholder vote on their proposed business combination for late July 2026.
If you've been watching the SPAC space, here's one to put on your calendar. Exascale Labs and D. Boral ARC Acquisition I Corp. — trading under the ticker BCAR — have officially set an Extraordinary General Meeting of shareholders for Wednesday, July 29, 2026. The sole purpose of that meeting? Getting shareholders to sign off on their proposed business combination.
For the uninitiated, a SPAC (Special Purpose Acquisition Company) is essentially a publicly traded shell company that raises money with one goal in mind: find a private company, merge with it, and take that company public without the traditional IPO process. D. Boral ARC Acquisition I Corp. is playing that role here, with Exascale Labs as its merger target.
Read more Downing LLP Files Disclosure Form for Animalcare Group Plc →
The Extraordinary General Meeting is a pretty standard step in the SPAC playbook. Shareholders of BCAR will gather — either in person or virtually — to cast their votes on whether the deal should move forward. If the majority approves, the two entities combine and Exascale Labs effectively becomes a publicly traded company.
While the announcement confirms the date and the parties involved, additional details about deal terms, valuation, or what Exascale Labs actually does have not been disclosed in this release. Investors holding BCAR shares will want to review the full proxy materials when they become available to understand exactly what they're voting on before July 29 rolls around.
Continue reading at GlobalNewswire.
